Total Payments
$15,862
2022 Payments
$2,157
Companies
79
Transactions
644
Medicare Patients
5,576
Medicare Billing
$721,880
Payment Breakdown by Category
Food & Beverage$11,458 (72.2%)
Consulting$2,888 (18.2%)
Gifts$1,010 (6.4%)
Education$506.42 (3.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,458 | 615 | 72.2% |
| Consulting Fee | $2,888 | 2 | 18.2% |
| Gift | $1,010 | 12 | 6.4% |
| Education | $506.42 | 15 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,963 | 30 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $1,910 | 20 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $1,753 | 50 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $1,107 | 68 | $0 (2022) |
| Genentech USA, Inc. | $936.86 | 49 | $0 (2022) |
| Amgen Inc. | $577.69 | 25 | $0 (2022) |
| Pharmacyclics LLC, an AbbVie Company | $557.16 | 20 | $0 (2022) |
| Celgene Corporation | $514.47 | 22 | $0 (2022) |
| PFIZER INC. | $512.62 | 38 | $0 (2021) |
| Incyte Corporation | $429.51 | 11 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $2,157 | 40 | AstraZeneca Pharmaceuticals LP ($1,403) |
| 2021 | $1,483 | 75 | E.R. Squibb & Sons, L.L.C. ($158.64) |
| 2020 | $1,398 | 87 | Pharmacyclics LLC, An AbbVie Company ($189.46) |
| 2019 | $4,902 | 160 | Bayer HealthCare Pharmaceuticals Inc. ($1,693) |
| 2018 | $1,602 | 93 | ASD Specialty Healthcare, LLC ($274.62) |
| 2017 | $4,321 | 189 | Novartis Pharmaceuticals Corporation ($808.20) |
All Payment Transactions
644 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2022 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $14.76 | General |
| 10/17/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: ONCOLOGY | ||||||
| 09/01/2022 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: ONC | ||||||
| 08/29/2022 | CTI BioPharma Corp. | Vonjo (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Hematology | ||||||
| 08/26/2022 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Oncology | ||||||
| 08/22/2022 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Consulting Fee | Cash or cash equivalent | $1,387.50 | General |
| Category: Oncology | ||||||
| 08/22/2022 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $19.84 | General |
| 05/16/2022 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $24.38 | General |
| Category: Hematology | ||||||
| 05/05/2022 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $82.43 | General |
| Category: ONC | ||||||
| 04/29/2022 | Genentech USA, Inc. | Alecensa (Biological), TECENTRIQ, ROZLYTREK | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: BioOncology | ||||||
| 04/26/2022 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: ONC | ||||||
| 04/25/2022 | Genentech USA, Inc. | GAZYVA (Biological), VENCLEXTA, POLIVY | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: BioOncology | ||||||
| 04/22/2022 | Genentech USA, Inc. | Phesgo (Biological) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: BioOncology | ||||||
| 04/20/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.62 | General |
| 04/15/2022 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $21.09 | General |
| Category: Hematology | ||||||
| 04/12/2022 | GENZYME CORPORATION | LIBTAYO (Biological), LIBTAYO, LIBTAYO | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Oncology | ||||||
| 04/11/2022 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $23.18 | General |
| 04/08/2022 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Oncology | ||||||
| 04/05/2022 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $17.29 | General |
| Category: Oncology | ||||||
| 04/04/2022 | AMAG Pharmaceuticals, Inc. | FERAHEME (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: For the treatment of iron deficiency anemia associated with chronic kidney disease | ||||||
| 03/30/2022 | Celgene Corporation | ONUREG (Drug) | Food and Beverage | Cash or cash equivalent | $13.50 | General |
| Category: Oncology | ||||||
| 03/25/2022 | Janssen Biotech, Inc. | IMBRUVICA (Drug), DARZALEX | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Oncology | ||||||
| 03/22/2022 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), FEMARA | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: ONCOLOGY | ||||||
| 03/21/2022 | Genentech USA, Inc. | Phesgo (Biological) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: BioOncology | ||||||
| 03/15/2022 | Sobi, Inc | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 73 | 82 | $21,655 | $6,821 |
| 2022 | 45 | 1,681 | 65,883 | $560,734 | $139,226 |
| 2021 | 54 | 2,756 | 75,583 | $965,854 | $275,566 |
| 2020 | 19 | 1,066 | 36,784 | $959,758 | $300,268 |
Total Patients
5,576
Total Services
178,332
Medicare Billing
$721,880
Procedure Codes
121
All Medicare Procedures & Services
121 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 35 | 35 | $12,082 | $3,445 | 28.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 30 | $5,334 | $1,822 | 34.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 17 | $4,239 | $1,554 | 36.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 12 | 1,740 | $88,740 | $29,911 | 33.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 102 | 224 | $53,536 | $14,777 | 27.6% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 43 | 112 | $42,336 | $11,937 | 28.2% |
| Q5101 | Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | Office | 2022 | 22 | 44,760 | $89,520 | $10,542 | 11.8% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2022 | 13 | 11,220 | $44,880 | $9,181 | 20.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 68 | 68 | $25,564 | $7,582 | 29.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 50 | 89 | $25,365 | $7,399 | 29.2% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2022 | 13 | 40 | $16,000 | $6,390 | 39.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 47 | 102 | $19,221 | $5,360 | 27.9% |
| J0185 | Injection, aprepitant, 1 mg | Office | 2022 | 11 | 3,770 | $18,850 | $5,323 | 28.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 205 | 467 | $13,543 | $3,620 | 26.7% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 21 | 60 | $12,360 | $3,589 | 29.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 65 | 228 | $15,680 | $2,546 | 16.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 152 | 221 | $8,619 | $2,328 | 27.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $8,526 | $2,208 | 25.9% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2022 | 36 | 171 | $10,403 | $2,208 | 21.2% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2022 | 31 | 78 | $6,520 | $1,907 | 29.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 14 | $4,746 | $1,386 | 29.2% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2022 | 17 | 41 | $6,381 | $1,134 | 17.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 180 | 370 | $3,330 | $1,107 | 33.2% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2022 | 16 | 51 | $2,856 | $869.71 | 30.5% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2022 | 13 | 35 | $2,765 | $847.91 | 30.7% |
About Dr. Ashok Bapat, M.D
Dr. Ashok Bapat, M.D is a Internal Medicine healthcare provider based in Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1518960384.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashok Bapat, M.D has received a total of $15,862 in payments from pharmaceutical and medical device companies, with $2,157 received in 2022. These payments were reported across 644 transactions from 79 companies. The most common payment nature is "Food and Beverage" ($11,458).
As a Medicare-enrolled provider, Bapat has provided services to 5,576 Medicare beneficiaries, totaling 178,332 services with total Medicare billing of $721,880. Data is available for 4 years (2020–2023), covering 121 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology, Medical Oncology
- Location Fort Myers, FL
- Active Since 05/24/2005
- Last Updated 12/15/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1518960384
Products in Payments
- Vitrakvi (Drug) $1,675
- LYNPARZA (Drug) $1,550
- KISQALI (Drug) $1,209
- OPDIVO (Biological) $736.51
- Imbruvica (Drug) $502.53
- Revlimid (Drug) $314.80
- ZEJULA (Drug) $286.39
- Kyprolis (Biological) $274.30
- KEYTRUDA (Biological) $272.07
- Alecensa (Biological) $221.61
- PROMACTA (Drug) $218.60
- Avastin (Biological) $210.86
- JAKAFI (Drug) $210.07
- CALQUENCE (Drug) $181.22
- JEVTANA (Drug) $180.70
- Lenvima (Drug) $179.66
- Trodelvy (Drug) $177.11
- IBRANCE (Drug) $175.85
- Xermelo (Drug) $172.76
- Folotyn (Drug) $170.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fort Myers
Dr. Michael Oleksyk, Md, MD
Internal Medicine — Payments: $570,596
Internal Medicine $570,596
Dr. Malissa Wood, Md, MD
Internal Medicine — Payments: $377,298
Internal Medicine $377,298
Oliver Abela, Md, MD
Internal Medicine — Payments: $70,958
Internal Medicine $70,958
Francisco De Jesus Paulino, Md, MD
Internal Medicine — Payments: $50,407
Internal Medicine $50,407
Dr. Vinayak Thakur, M.d, M.D
Internal Medicine — Payments: $19,038
Internal Medicine $19,038
Imtiaz Ahmad, Md, MD
Internal Medicine — Payments: $18,331
Internal Medicine $18,331